Identify effective testing modalities for biomarker assessment in non-small cell lung cancer (NSCLC) Summarize recent NSCLC trial results and recognize how they affect current clinical practice Identify new potential indications for MET inhibitors within NSCLC, such as a combination approach for EGFR TKI resistance Integrate guidelines, patient preferences, and treatment adherence into NSCLC treatment planning strategies
- Provider:Global Learning Collaborative
- Activity Link: https://reachmd.com/programs/17986
- Start Date: 2024-10-01 05:00:00
- End Date: 2024-10-01 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.75 hours
AMA PRA Category 1 Credit™️: 0.75 hours
Nursing: 0.75 hours
Pharmacy: 0.75 hours - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest